Loading...
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Products:Cell Biology >> Apoptosis >> Intracellular >> Associated Proteins
Anti-GTPase HRAS antibody [Y13-259]
See all GTPase HRAS products (5) ...
Rat monoclonal [Y13-259] to GTPase HRAS
This antibody does not cross-react with rap.
Flow Cyt, ICC, IHC-Fr, IHC-P, WB, IPmore details
Reacts with
Mouse, Rat, Human
Recombinant full length protein.
Within amino acids 62-76 of v-H-Ras.
SW480 or Y1 cells (IP, IB, IF) or normal skin tissue (IHC).
Liquid
Store at +4°C. Do not freeze.
Preservative: 0.1% Sodium Azide
Constituents: 0.2% Gelatin, 0.05M Sodium phosphate
Concentration information loading...
Protein G purified
Monoclonal
Y13-259
Y3/Ag1.2.3
IgG1
Cancer >> Signal transduction >> G protein signaling >> Small G proteins >> Ras family
Epigenetics and Nuclear Signaling >> Transcription >> Cancer susceptibility >> Proto-oncogenes
Cell Biology >> Cell Cycle >> Cell differentiation
Signal Transduction >> Signaling Pathway >> G Protein Signaling >> Small G Proteins >> Ras Family
Cell Biology >> Apoptosis >> Intracellular >> Associated Proteins
Flow Cytometry - Anti-GTPase HRAS antibody [Y13-259] (ab16881)
(enlarge)
Our Abpromise guarantee covers the use of ab16881 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Flow Cyt: Use 1µg for 106 cells.
ICC: Use a concentration of 2.5 µg/ml
IHC-Fr: Use a concentration of 5 µg/ml
IHC-P: Use a concentration of 5 µg/ml
WB: Use a concentration of 2.5 µg/mlPredicted molecular weight: 21 kDa.
IP: Use a concentration of 1 µg/ml
Ras proteins bind GDP/GTP and possess intrinsic GTPase activity.
Defects in HRAS are the cause of Costello syndrome (COSTS) [MIM:218040]; also known as faciocutaneoskeletal syndrome. Costello syndrome is a rare condition characterized by prenatally increased growth, postnatal growth deficiency, mental retardation, distinctive facial appearance, cardiovascular abnormalities (typically pulmonic stenosis, hypertrophic cardiomyopathy and/or atrial tachycardia), tumor predisposition, skin and musculoskeletal abnormalities.
Defects in HRAS are the cause of congenital myopathy with excess of muscle spindles (CMEMS) [MIM:218040]. CMEMS is a variant of Costello syndrome.
Defects in HRAS may be a cause of susceptibility to Hurthle cell thyroid carcinoma (HCTC) [MIM:607464]. Hurthle cell thyroid carcinoma accounts for approximately 3% of all thyroid cancers. Although they are classified as variants of follicular neoplasms, they are more often multifocal and somewhat more aggressive and are less likely to take up iodine than are other follicular neoplasms.
Note=Mutations which change positions 12, 13 or 61 activate the potential of HRAS to transform cultured cells and are implicated in a variety of human tumors.
Defects in HRAS are a cause of susceptibility to bladder cancer (BLC) [MIM:109800]. A malignancy originating in tissues of the urinary bladder. It often presents with multiple tumors appearing at different times and at different sites in the bladder. Most bladder cancers are transitional cell carcinomas. They begin in cells that normally make up the inner lining of the bladder. Other types of bladder cancer include squamous cell carcinoma (cancer that begins in thin, flat cells) and adenocarcinoma (cancer that begins in cells that make and release mucus and other fluids). Bladder cancer is a complex disorder with both genetic and environmental influences.
Note=Defects in HRAS are the cause of oral squamous cell carcinoma (OSCC).
Belongs to the small GTPase superfamily. Ras family.
Palmitoylated by the ZDHHC9-GOLGA7 complex. A continuous cycle of de- and re-palmitoylation regulates rapid exchange between plasma membrane and Golgi.
S-nitrosylated; critical for redox regulation. Important for stimulating guanine nucleotide exchange. No structural perturbation on nitrosylation.
Cell membrane. Golgi apparatus membrane. Shuttles between the plasma membrane and the Golgi apparatus.
Target information above from: UniProt accessionP01112
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Flow Cytometry - Anti-GTPase HRAS antibody [Y13-259] (ab16881)
![Flow Cytometry - Anti-GTPase HRAS antibody [Y13-259] (ab16881)](/ps/datasheet/images/16/ab16881/GTPase-HRAS-Primary-antibodies-ab16881-1.jpg)
Overlay histogram showing HeLa cells stained with ab16881 (red line). The cells were fixed with 80% methanol (5 min) and incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab16881, 1µg/1x106 cells) for 30 min at 22ºC. The secondary antibody used was DyLight® 488 goat anti-rat IgG (H+L) (ab98386) at 1/500 dilution for 30 min at 22ºC. Isotype control antibody (black line) was rat IgG1 [RTK2071] (ab18412, 2µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HeLa cells fixed with 4% paraformaldehyde (10 min) used under the same conditions.
Please note that Abcam do not have any data for use of this antibody on non-fixed cells. We welcome any customer feedback.
This product has been referenced in:
See all 2 publications for this product
Publishing research using ab16881? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
![Flow Cytometry - Anti-GTPase HRAS antibody [Y13-259] (ab16881)](/ps/datasheet/images/16/ab16881/GTPase-HRAS-Primary-antibodies-ab16881-1.jpg)
Overlay histogram showing HeLa cells stained with ab16881 (red line). The cells were fixed with 80% methanol (5 min) and incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab16881, 1µg/1x106 cells) for 30 min at 22ºC. The secondary antibody used was DyLight® 488 goat anti-rat IgG (H+L) (
Please note that Abcam do not have any data for use of this antibody on non-fixed cells. We welcome any customer feedback.
0
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
